- Heart Test Laboratories ( NASDAQ: HSCS ) said it had been granted a patent in Israel for its ECG, MyoVista Wavelet technology, using artificial intelligence ( AI ) for early detection of heart disease.
- An electrocardiogram (ECG or EKG) records the electrical signal from the heart to check for heart conditions.
- HeartSciences has been granted nine US patents and 31 international patents.
- The Company has 8 patents pending to be approved in the U.S. and international markets.
- "Artificial intelligence is transforming what’s possible, and at HeartSciences we are at the leading edge of changing what’s possible with an ECG by applying AI to make it a far more valuable screening tool for heart disease detection to save lives," the company said.
- ( HSCS ) down 11.5% before the bell.
For further details see:
HeartSciences granted Israeli patent for ECG